Loading data
ARLONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 296.46 m USD | 323.38 m USD | 323.61 m USD | 354.38 m USD | 327.1 m USD |
| Gross profit | 232.84 m USD | 187.5 m USD | 167.56 m USD | 136.04 m USD | 108.04 m USD |
| Research and development expense | 73.65 m USD | 73.18 m USD | 68.65 m USD | 64.71 m USD | 59.06 m USD |
| Operating profit | 6.07 m USD | -34.89 m USD | -24.9 m USD | -56.88 m USD | -60.14 m USD |
| Profit before tax | 15.67 m USD | -29.41 m USD | -20.86 m USD | -55.65 m USD | -55.35 m USD |
| Income tax expense | 741 k USD | 1.09 m USD | 1.18 m USD | 975 k USD | 677 k USD |
| Net income (reported basis) | 14.93 m USD | -30.5 m USD | -22.04 m USD | -56.63 m USD | -56.03 m USD |
| Basic earnings per share | 0.14 USD/share | -0.31 USD/share | -0.24 USD/share | -0.65 USD/share | -0.68 USD/share |
| Diluted earnings per share | 0.14 USD/share | -0.31 USD/share | -0.24 USD/share | -0.65 USD/share | -0.68 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.